Plaintiff
5 cases as plaintiff.
Oxysales, UAB is a private Lithuanian technology company headquartered in Vilnius, Lithuania, founded in 2015. It is the legal entity behind the "Oxylabs" brand, a prominent provider in the proxy service industry. While some public registries indicate Oxysales, UAB itself currently has no registered employees, the Oxylabs operation is stated to employ over 300 professionals. Oxysales, UAB is part of a corporate group that includes Teso LT, UAB and Metacluster LT, UAB, stemming from a restructuring of Tesonet, and these entities share common ownership and control.
The company's core business, through its Oxylabs brand, focuses on offering web data collection solutions. Its major product lines and services include residential and data center proxy networks, scraper APIs, and datasets designed to facilitate large-scale public web data extraction. These services cover various layers of data extraction, from connection and access to scraping and data delivery.
In terms of patent litigation, Oxysales, UAB operates as a defendant in its single tracked case, indicating an operating company posture defending against intellectual property challenges rather than asserting patents as a non-practicing entity. The company is recorded as a defendant in Bright Data, Ltd. v. Teso LT, UAB et al. in the U.S. District Court for the Eastern District of Texas, a venue known for its plaintiff-friendly docket.
The notable case, Bright Data, Ltd. v. Teso LT, UAB et al., filed by Bright Data, Ltd. (formerly Luminati Networks Ltd.), an Israeli technology company also engaged in web data platform and proxy services, alleges patent infringement related to proxy technology. Oxysales, UAB, alongside Teso LT, UAB and Metacluster LT, UAB, was named as a defendant following a corporate restructuring of Tesonet in late 2018.
Watchlist
Email-only, free, anonymous. We'll notify you when Oxysales, UAB files another patent-infringement lawsuit. One-click unsubscribe from any alert.
IPR petition challenging claims 1, 2, 6–11, 13, 15, 16, and 18–23 of U.S. Patent 11,044,342. The PTAB instituted on all challenged claims and grounds and issued a Final Written Decision on May 30, 2023 holding all challenged claims unpatentable.
Inter partes review petition filed by Teso LT, UAB, Code200, UAB, Metacluster LT, UAB, and Oxysales, UAB against Luminati Networks Ltd. challenging U.S. Patent No. 10,637,968. The PTAB denied institution on June 2, 2021.
Inter partes review petition challenging claims 1-5, 9, 14, 17, 20-22, 25, and 27-30 of the '511 patent. The Board denied institution on April 20, 2021, based in part on the advanced stage of the parallel Code200 litigation.
Inter partes review petition filed by Code200, Teso, Metacluster, and Oxysales challenging claims of U.S. 10,469,614. The PTAB denied institution on February 16, 2021.
Petitioners Code200, UAB, Teso LT, UAB, Metacluster LT, UAB, and Oxysales, UAB challenged claims 1, 2, 6–11, 13, 16, 18–25, 29–34, 36, 39, 41–46 of the '344 patent. The PTAB instituted on July 1, 2022, and issued a Final Written Decision holding all challenged claims unpatentable over Reiter et al.